Simmitecan (hydrochloride)
Simmitecan hydrochloride, a 9-substituted lipophilic Camptothecin derivative, is a potent topoisomerase I inhibitor. Simmitecan hydrochloride is an anticancer agent[1][2].
Product Specifications
CAS Number
1247847-78-4
UNSPSC
12352005
Target
Cytochrome P450; Topoisomerase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/simmitecan-hydrochloride.html
Solubility
10 mM in DMSO
Smiles
[H]Cl.CC[C@]1(O)C(C=C2N3CC4=CC5=C(C=CC(OC(N6CCC(N7CCCCC7)CC6)=O)=C5CC=C)N=C42)=C(COC1=O)C3=O
Molecular Formula
C34H39ClN4O6
Molecular Weight
635.15
References & Citations
[1]Rini B, et al. A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma. Ann Oncol. 2014 Sep;25 (9) :1794-1799. |[2]Hu ZY, et al. Pharmacokinetic evaluation of the anticancer prodrug simmitecan in different experimental animals. Acta Pharmacol Sin. 2013 Nov;34 (11) :1437-48.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-P718310-100MG 100 mg
N-3-Pyridinyl-9-acridinamine Hydrochloride
Sign In for Pricing
View Details 
BNC882028-500 1x 500 µL
ARF1 (Golgi Apparatus Marker) (1A9/5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC403202 20 µg
GPR128 (ADGRG7) (NM_032787) Human Over-expression Lysate
Sign In for Pricing
View Details